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We have reported that microRNAs (miRNAs, miRs) in bovine milk regulate
human genes. In milk, many miRNAs are encapsulated in exosomes, thereby conferring
protection against degradation and a pathway for intestinal transport of miRNAs. We
hypothesized that the uptake of bovine exosomes in human intestinal colon carcinoma
Caco-2 cells and rat primary small intestinal IEC-6 cells is mediated by endocytosis.
Transport studies were carried out using fluorophore-labeled exosomes purified from
bovine milk. The transport of bovine exosomes exhibited saturation kinetics at 37°C
(Km= 55.5±48.6 µg/200 µL, Vmax= 0.083±0.057 ng exosomal protein x 81,750 cells−1 x
hr−1) and decreased by 60% if transport was measured at 4°C in Caco-2 cells, consistent
with carrier-mediated transport. Inhibitors of vesicle trafficking and carbohydrate
competitors caused a 62-85% and 61-83% decrease, respectively, in exosome transport,
consistent with cellular transport of bovine exosomes by endocytosis that depends on
surface glycoproteins in Caco-2 cells. Similar patterns were observed in IEC-6 cells.
When milk exosomes at a concentration of five times the Km were added to the upper
chamber in transwell plates, Caco-2 cells accumulated miR-29b in the lower chamber,
whereas reverse transport was minor. We conclude that the uptake of bovine milk

exosomes is mediated by endocytosis and depends on cell and exosome surface
glycoproteins in human and rat intestinal cells.
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CHAPTER 1
LITERATURE REVIEW

2

Extracellular Vesicles

. Extracellular vesicles (EVs) are secreted by the plasma membrane (1) and range 30-1000
nm in size (2). They are released from many cell types, such as epithelial cells (3), tumor
cells (4), and neurons (5). Post-transciption modications (6), intercellular communcation
(7), and exchange of genetic material in both eukaryote and prokarytoic cell types (8, 9)
are just a few of the notable functional capablities of EVs. These membrane inclosed
vesicles are spherical in shape (10), and when mounted for negative staining to be viewed
by transmission electron microscopy (TEM), they appear cup-shapped (1, 11).

History and Mechanism of Action

EVs are found in many biologial fluids, such as urine (12, 13), blood (14), salvia
(15), and breast milk (16). The major catergories of EVs include exosomes,
microvesicles, and apopotoic bodies (Table 1). Table 1 summarizes the main differences
between them.
In 1967, Peter Wolf visualized EVs with electron microscopy and described the
vesicles as platlet dust while doing coagulation research (17). By 1971 one of Wolf’s
collegues used electron micrographs to visualize EVs from pig plasma which he
described as having a “heterogenous granular“ apppearance (18) . Using
ultracentrfiguation, George et al. in 1982 analyzed the microvesicles populations in the
resulting pellets of human sera and plasma with an immunoelectrophoretic assay. They
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discovered circulating micropartices originate from elsewhere in the human body, not just
blood platelets as initially thought (19). Research progress has discovered a role for EVs
in intracellular and extracellular communication (1, 7), immune response (7, 20, 21) and
the delivery of exogenous compounds to recepient cells (8, 22, 23). For the purposes of
this review, the primary focus will be exosomes.

Vesicles:

Table 1. Characteristics of different eukaryotic types of
cell derived extracellular vesicles
Exosome
Microvesicles

Apoptotic bodies

(Ectosomes)
Diameter
(nm)

30-150

100-1,000

50-5000

Density
(g/ml)

1.13-1.19

Unknown

Unknown

Formation

Exocytosis of
MVBs

Budding of
plasma
membrane

Release from
dying/apoptotic
cells

Morphology Cup-shaped
(TEM)

Irregular
shape

Heterogeneous

Origin

Endosomes

Plasma
membrane

Blebs released from
cells undergoing
apoptosis

Protein
Enrichment

C81, CD63, CD9,
LAMP1, Alix,
TSG101

MMP2,
Annexin V,
integrins,
selectins,
CD40 ligands

Histones, Annexin
V

Adapted from (1, 11, 24-33)

4

Exosomes
The literature is well established that many cell types shed small vesicles into the
extracelluar space. Exosomes are a type of extracellular vesicles that are secreted from
various cells types by multivesicular bodies (MVBs) fusing with the plasma membrane
(25, 32, 33). Endosomal exosome biogensis occurs by the inward budding of the plasma
membrane into multivesicular bodies (MVBs). Johnston et al. proposed the term exosome
be given to EVs that originate from MVBs (34). According to the International Society
for Extracellular Vesicles, the term exosomes is the most popular word used to classify
any type of extracellular vesicle (35).
Exosomes range 30-150 nm in sizes and mediate the transfer of microRNA
between cells (30, 31, 36). Raposo et al. demonstrated B cell lymphocyte exosomes play
a role in extracelluar commication by eliciting specific T cell responses (1). Dedendritic
cell-derived exosomes can diminish the establishment of murine tumors, reinforcing their
role in immune response (7). Numerous other studies have demonstrated the role of
exosomes in cell to cell signaling activities (37, 38).

Composition
Exosomes are enriched in proteins, and as a result have been associated with
specific proteins for indication of their presence. Identification of exosomes became more
appart when proteins that are involved with MVB biogensis were detected in exosomes
(7, 39). Currently, over 4,500 proteins have been identified in exosomes (40). Eight major
proteins have been identifited from murine dendritic derived exosomes, with heat shock
cognate protein 73 (hsc73) being adundant and shown to accumulate in the endocytic
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compartments of a murine spleen-derived cell line (41). According to ExoCarta, CD63 is
among the top 25 proteins that are often identified in exosomes (42). Other proteins
commonly used to identify exosomes include heat shock 70kDA protein 8 (HSPA8),
CD9, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta-actin (ACTB), CD81
and annexin A2 (ANXA2) (40). Though exosomes are enriched in many proteins,
additional research is needed to distinguish between exosomes and microvesicles if trying
to obtain pure isolates.
The lipid content of exosomes has not been studied as intensely as protein. Thus
far, studies that focus on exosomes secreted from cells contain saturated fatty acids,
cholesterol (43, 44), posphytileserine, and sphingomyelin (44, 45).

Transportation of Exosomes
The research suggests that cellular uptake of exosomes is mediated by an
endocytosis-dependent process (46-48) including phagocytosis (49), receptor-mediated
endocytosis (50), micropinocytosis (51) and macropinocytosis (see Figure 1.1) (52).
According to Tan et al., mescnehymal stem cell released exosomes from an endocytosed
lipid raft, suggesting their endosomal origin (53).
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Figure 1.1 Simplified uptake pathways for extracellular vesicles
[Figure source: Review by Mulcahy et al., 2014] (52)
How milk exosomes cross the intestinal muscosa needs further exploration, but
one can infer that it might be similar to human EVs. Recently, an independent laboratory
suggested that milk exosomes enter the mouse circulation intact by crossing the intestinal
mucosa without re-packaging (54). Exosomes secreted by mast cells that contain mRNA
and miRNA can be transferred to nearby cells and be operational (8, 55).
Rab proteins are small cytostolic GTPases that are known to control important
steps in vesicle formation and trafficking (56). As a result, exosomes of endosomal origin
contain proteins that are involved in membrane transport and fusion processes (see Figure
1.2 B) (57). A group of the Rab proteins have been shown to be involved in exosome
secretion. For instance, Rab35 is involved in transporting proteolipid protein from a
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murine oligodendroglial cell MVBs to exosomes (58). The negative dominant mutant of
Rab35 decreased exosomes release in an erythroleukemia cell line (59). Knock down of
five Rab proteins: Rab27, Rab2b, Rab5a, Rab9a, and Rab27A, in HeLa cells inhibited
exosomes secretion dramatically demonstrating their important role in exosomes
secretion (60).
By using inhibitors of transport processes, researchers can gain insight on
exosomes methods of entry and secretion from cells. According to Escrevente et al.,
treatment of ovarian tumor cells with the inhibitor cytochalasin D, resulted in a 36 +/13% reduction in cell uptake of isolated labeled SKOV3 cell exosomes (61). A study
using a transwell system treating Caco-2 cells with 10 uM of cytochalsin D caused nearly
complete depolymerization of actin stress fibers (62). Guanine nucleotide exchange
protein (BIG2) is a factor involved in ADP-ribosylation (63, 64). Brefeldin A has been
shown to target ADP-ribosylation factor that is responsible for coat proteins associated
with clathrin-coated vesicles (65).
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Figure 1.2. Exosomes composition and extracellular vesicles origin of exosomes (a),
ectosomes (b), and apoptotic bodies (c).
(B) Exosomes are composed RAB proteins, annexins ,adhesion molecules and
tetraspanins, cytoskeletal proteins, and miRNA. Membranes are enriched in raft lipids
such a cholesterol, spingolipids, and ceramide. Abbreviations: ALIX- apoptosis-linked
gene 2-interacting protein X, ERM- ezrin radixin moesin, HSP70-Heat shock protein 70,
TSG101- tumor susceptibility gene 101, ICAM- intercellular cell adhesion molecule.
Figure adapted from Mittelbrunn et al., 2012 (57).

Isolation of Extracellular Vesicles
The initial process used to isolate EVs was based on differential centriguation to
remove vesicles larger than EVs (1, 7, 34). The final ultracentifugation step typically
includes a G-force of at least 100,000 x g to pellet the exosomes (66). Centrifuge runs as
high as 140,000 g has been used to sediment exosomes as well (67). To ensure that
aggregates aren’t formed, some researchers use a sucrose cushion, where the aggrages
sink though the sucrose, and the lipid containing EVs float on the correct density.
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Exosomes float in sucrose gradients between the density of 1.13-1.19 g/mL (26). Though
because this method is tedious, it’s losing popularity for exosome isolation since more
convenient methods are currently being developed. Iodizanol Optiprep™ (Axis-Shield
PoCAS) has recently been used with differnetial centrifugation to obtain more pure
exosomes (68). Recent reports also suggest improved separation from apopototic bodies
and viruses (69). Anti-body coated beads (HansaBioMed) and polymer based precipation
kits (exoquick) are other methods that have become available for isolation of extracellular
vesicles. An in-depth investigation of all methods of isolation for EVs is needed, as there
is currently no gold standard recommendation for pure isolation of EVs.

MicroRNA
MicroRNAs are 19 to 25 nucleotides long (70, 71) noncoding RNAs, that typically bind
to the 3’ UTR of target mRNAs leading to mRNA break down or translational delay (72,
73). In the nucleus, microRNA is encoded by its own genes and transcribed by RNA
polymerase II or RNA polymerase III (73, 74), followed by cleavage of the miRNA
transcript by a complex called Drosha (75). The hairpin loop miRNA structure is then
transported into the cytoplasm where the premature miRNA is further processed by dicer
(76, 77), resulting in double stranded mature miRNA. The mature miRNA typically bind
to the 3’ UTR of target mRNAs leading to mRNA break down or translational delay (72,
73) (see Figure 1.3) (78).
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Figure 1.3 The biogenesis of MicroRNA [Figure source: Joshi et al., 2011] (78)

Many mammalian microRNAs are found in introns or exons of long noncoding
transcripts (73). Though the majority of human miRNAs are found 8937 intracellularly,
they are also present in extracellular fluids such as cell culture supernatants (8, 55), urine
(79), saliva (80), and milk (81). Extracellular miRNA in the plasma and serum has been
found directly bound to Argonaute2 as part of the RISC complex (RNA induced silencing
complex), which makes them resistant to degradation by exonucleases (82). In the
plasma, miRNA has been shown to be delivered to cells by with high-density lipoproteins
(83).
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A pivotal study in 2007 revealed that exosomes from MC/9, BMMC, and HMC-1
cells contained a large amount of RNA, and miRCURY LNA Array detected 121
microRNAs (8). Many miRNAs can be found encapsulated in exosomes in human serum
and saliva (84). MicroRNAs have also been detected in exosome originating from cells
(55, 85, 86) and from malignant tumors (55).

Bovine MicroRNA
In milk, many miRNAs are encapsulated in extracellular vesicles, such as
exosomes, thereby conferring protection against degradation and a pathway for intestinal
transport of miRNAs. MiR-29b is moderately abundant in cow’s milk, and plays a role in
bone health (87). MiR-200c is highly abundant in cow’s milk, and plays a role in cancer
prevention by causing dependent loss of transcription factor ZEB1 (88). MiR-29b
stimulates osteoblast differentiation (89, 90), impairs osteoclast differentiation and as a
result, promotes bone health through increasing bone mineral density (91). Recent studies
have been conducted isolating exosomes from human and bovine milk that contain
miRNA (92-94), as well as plants. Baier et al. was able to detect increased levels of miR200c and miR-29b after consumption of cow’s milk in human plasma (92).

Other Dietary MicroRNA
The first report of plant miRNAs having the potential to modulate human genes
was 3 years ago. Zang et al. high in rice, which contains miR-168a, could be detected in
the human and animal sera (95). Thus far, other researchers have not been able to
replicate their results (92, 96-99). In contrast to mammalian microRNAs, plant miRNAs
are methylated at the 3’-terminal ribose by methyl transferase HEN1 (100).
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Farmer et al. recently showed that miR-2911 from honeysuckle was detected in
mouse sera and urine after consumption (101). Human subjects fed broccoli sprouts had
no detectable increase in broccoli borne miR-824 and miR-167a in human blood (92).
Continued research in the microRNA research field is needed to confirm if dietary
microRNAs can affect human health in physiological relevant concentrations.
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Abstract
We have reported that microRNAs (miRNAs, miRs) in bovine milk regulate human
genes. In milk, many miRNAs are encapsulated in exosomes, thereby conferring
protection against degradation and a pathway for intestinal transport of miRNAs. We
hypothesized that the uptake of bovine exosomes in human intestinal colon carcinoma
Caco-2 cells and rat primary small intestinal IEC-6 cells is mediated by endocytosis.
Transport studies were carried out using fluorophore-labeled exosomes purified from
bovine milk. The transport of bovine exosomes exhibited saturation kinetics at 37°C
(Km= 55.5±48.6 µg/200 µL, Vmax= 0.083±0.057 ng exosomal protein x 81,750 cells−1 x
hr−1) and decreased by 60% if transport was measured at 4°C in Caco-2 cells, consistent
with carrier-mediated transport. Inhibitors of vesicle trafficking and carbohydrate
competitors caused a 62-85% and 61-83% decrease, respectively, in exosome transport,
consistent with cellular transport of bovine exosomes by endocytosis that depends on
surface glycoproteins in Caco-2 cells. Similar patterns were observed in IEC-6 cells.
When milk exosomes at a concentration of five times the Km were added to the upper
chamber in transwell plates, Caco-2 cells accumulated miR-29b in the lower chamber,
whereas reverse transport was minor. We conclude that the uptake of bovine milk
exosomes is mediated by endocytosis and depends on cell and exosome surface
glycoproteins in human and rat intestinal cells.

Key words: endocytosis; epithelial cell; extracellular vesicles; milk exosomes; bovine
milk exosomes; uptake
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INTRODUCTION
The literature is well established that many cell types shed small vesicles into the
extracellular space. Evidence suggests that exosomes mediate the transfer of microRNA
(miRNA) between cells (1, 2). Our lab is the first to show that humans absorb meaningful
quantities of mircoRNA-29b (miR-29b) and miR-200c from nutritionally relevant
amounts of cow’s milk (3). Baier et al. also showed these miRNAs can affect expression
in vitro, and that endogenous synthesis does not compensate for dietary miRNA loss in
mice (3). MiR-29b is moderately abundant in cow’s milk, and plays a role in bone health
(4) by repressing runt-related transcription factor 2 (RUNX2) inhibitors (5, 6), and as a
result increases bone mineral density (7). MiR-200c is highly abundant in cow’s milk,
and plays a role in cancer prevention by inhibiting the transcription factor zinc finger Ebox binding homebox 1 (ZEB1), thereby limiting epithelial-to-mesenchymal transition
(8, 9).
Mature microRNAs (miRNAs) are small noncoding RNAs that typically bind to
the 3’ UTR of target mRNAs, leading to mRNA break down or translational delay (10,
11). The emerging evidence of human miRNAs modulating human genes has sparked an
interest in dietary miRNAs to see if they also play a role in human health. Many
microRNAs in milk are protected against degradation (12) by encapsulation in exosomes
(13, 14). In 2007, it was discovered that exosomes carry mRNA and miRNA (15). In this
study it was demonstrated that a human mast cell line expressed mouse specific proteins
after treatment with mouse exosomal mRNA. This important finding indicated that
mRNA transported via the exosomes is translated and may hold importance in overall
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cell function (15). The aim of our study was to determine mechanisms of milk exosome
cellular uptake. This study can help provide further evidence if food miRNAs protected
by exosomes can gain entry into human colon carcinoma Caco-2 and rat IEC-6 primary
small intestinal cells. Cow’s milk contains 245 microRNAs (16) and bioinformatics
predictions suggest that 175 of those might interact with 11,199 human transcripts
(unpublished data).
In this study we describe studies of human colon carcinoma Caco-2 cells (Caco-2)
as a model system for studies of the uptake into human colon cells. We speculate that
milk exosomes are absorbed in the small intestine, therefore we also use a rat small
intestine epithelial cell (IEC-6) as a model as well. We hypothesize the uptake of bovine
exosomes in human intestinal colon carcinoma Caco-2 cells and rat primary small
intestinal IEC-6 cells is mediated by endocytosis. Here we will characterize the uptake
kinetics of milk exosomes into Caco-2 and IEC-6 cells.

METHODS AND MATERIALS

Cell cultures. Human colon carcinoma Caco-2 cells were purchased from American Type
Culture Collection and were used from passage 52-72 for experiments cultured in
Dulbecco’s Modified Eagle Medium (DMEM) containing 1% non-essential amino acids,
10% fetal bovine serum (FBS), 1% L-glutamine, 100,000 U/L penicillin and 100 mg/L
streptomycin. In select experiments, Caco-2 cells were cultured for 2 days in exosomedepleted media obtained by ultracentrifugation of FBS at 120,000 x g for 6 hours. Cell
media was replaced with fresh media every 2 to 3 days. Transport studies were conducted
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at 75% confluence in 96-well plates and at 100% confluence in transwell plates. IEC-6
primary rat small intestinal cells were obtained from ATCC at passage 14, and cultured
as described for Caco-2 cells except that culture media contained 0.1 unit/mL bovine
insulin and that no transwell studies were conducted due to the IEC-6 cells’ inability to
form a tight monolayer.

Milk exosome isolation and fluorophore conjugation. Skim cow’s milk was purchased
in a local grocery store. The milk was centrifuged at 13,200 x g and 4°C for 30 minutes to
remove somatic cells and debris. The supernatant was mixed 1:1 (by volume) with 250
mM EDTA (pH 7.0) on ice for 15 minutes to precipitate milk casein(17). The suspension
was ultracentrifuged at 100,000 x g and 4°C for 60 minutes (F37L-8x100 rotor; Thermo
Scientific, USA) to remove precipitated protein, fat globules, and vesicles larger than
exosomes. The clear supernatant was ultracentrifuged at 120,000 x g for 90 minutes at
4°C to collect exosomes. The exosome pellet was re-suspended in a small volume of
phosphate-buffered saline containing 0.01% sodium azide, filtered twice through a 0.22µm membrane filter, and stored at 4°C and -20°C if necessary. The exosomes were
labeled with the fluorophore, FM 4-64 (Molecular Probes). One microliter of a stock
solution of FM 4-64 (.986 mM/L) was added to 1 mL of exosome suspension, incubated
for 15 minutes at 37°C and excess FM 4-64 was removed by ultracentrifugation at
120,000 x g at 4°C for 90 minutes.
Absence of aggregation and exosome purity was assessed as recommended by the
International Society for Extracellular Vesicles (18). Briefly, absence of exosome
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aggregation was confirmed using transmission electron microscopy (Hitachi H7500,
Japan) in the Microscopy Core Facility in the University of Nebraska-Lincoln (Fig. 1A).
ImageJ (http://imagej.nih.gov/ij/index.html) was used to analyze the exosome size
distribution. Exosome purity and identity was confirmed using whole protein extracts
from exosomes and gel electrophoresis (10 µg protein/lane) as described previously (19).
Membranes were probed using mouse anti-bovine CD63 (AbD Serotec, UK) as a marker
for exosomes, rabbit antiserum to bovine alpha s1-casein as a marker for the animal
species of exosome origin, and goat anti-bovine histone H3 (Santa Cruz Biotechnology,
USA) as a negative control (all at 1,000-fold dilutions). Bands were visualized using an
Odyssey infrared imaging system (Licor, Inc.) and IRDye 800CW-labeled secondary
antibodies at a 50,000-fold dilution (Fig. 1B).

Transport studies. Caco-2 cells and IEC-6 cells were seeded at a density of 20,000 cells
and 7,000 cells per well, respectively, in 96-well plates and allowed to adhere for 48
hours. Transport studies were conducted using FM4-64 labeled exosomes using 3-110 μg
exosomal protein/well (Caco-2 cells) or 27-652 μg exosomal protein/well (IEC-6 cells)
and incubating cells for periods of time described in Results; blanks were created using
solvent. Assays were calibrated by quantifying the fluorescence of a known mass of
exosomes labeled with FM 4-64. When indicated, cells or exosomes were treated with
100 μg/mL proteinase K (Caco-2 cells) to remove surface proteins, 10 μg/mL of the
endocytosis inhibitor cytochalasin D, 20 μg/mL of brefeldin A to inhibit vesicle
trafficking, and 150 mmol/L of the carbohydrate competitors D-glucose or D-galactose 30
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minutes before initiation of transport studies and continuing for the duration of transport
studies. IEC-6 cells did not survive proteinase K treatment. Therefore, surface proteins
were removed by treating IEC-6 cells and exosomes using 0.105 mmol/L for five and 30
minutes, respectively, at room temperature. Exosome uptake was analyzed by measuring
the cell fluorescence at 515 nm (excitation) and 640 nm (emission) using a Biotek
FLx800 plate reader and Gen5 data analysis software (BioTek, Winooski, VT).
Fluorescence readings were corrected for cell autofluoresence by subtracting signals
measured in cells incubated with exosome-depleted media. Transport kinetics were
modeled using the Michaelis-Menten equation and non-linear regression; modeling was
conducted using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA).
In transwell studies, Caco-2 cells were seeded at a density of 9,000 cells per well
and 75 μL media in 96-well polycarbonate plates with a pore size of 0.4 μm (EMD
Millipore, Billerica, MA), and allowed to grow a differentiated monolayer for 21-24 days
(20). Caco-2 cell monolayer integrity was formally confirmed using the Lucifer Yellow
(LY) rejection assay according to the manufacturer’s instructions at a final concentration
of 60 μmol/L (20). LY fluorescence was measured in the transwell apical and basolateral
chambers after one hour of incubation at 37°C (480 nm excitation, 530 nm for emission).
In parallel experiments, Caco-2 cells were cultured in exosome-depleted media to which
milk exosomes were added back to produce either a concentration of 275 μg/100 μL
exosomal protein in the upper, apical chamber or the lower, basolateral chamber.
Controls were cultured in exosome-depleted media. Aliquots of media were collected
from the upper chamber and bottom chamber after two hours of incubation for analysis of
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miRNAs. Twenty-five attomoles of internal standard (miSPIKE Synthetic RNA, IDT
Technologies) were added to samples prior to miRNA extraction using the nucleospin
miRNA plasma kit (Macherey-Nagel). The concentration of miR-29b in transwell
chambers was measured by quantitative real-time PCR, using miScript II RT kit, miScript
SYBR Green (Qiagen), and miRNA-specific primers (Table 2) as described previously
(3). Values were corrected for the internal standard to normalize for extraction efficiency.

Statistics. Homogeneity of variances was assessed using the Brown-Forsythe test (21,
22). The data variation for IEC-6 cells was heterogenous, i.e., those data were log
transformed prior to statistical analysis. Statistical significance of differences among
treatment groups was assessed using one-way ANOVA and Dunnett’s test for post hoc
comparisons between treatment groups and control. Analyses were performed using
GraphPad Prism. Differences were considered significant if P<0.05. Results were
presented as means ± S.D. and represent independent biological replicates.

RESULTS

Time course. In Caco-2 cells, exosome uptake at 37°C was linear for up to 120 minutes if
transport was measured using non-saturating substrate concentrations, i.e., 110 µg
exosomal protein/200 μL (Fig. 2A): y=0.001159x + 0.01355 (r2=0.969). In IEC-6 cells,
exosome uptake at 37°C was linear for only up to 60 minutes if transport was measured
using non-saturating substrate concentrations, i.e., 55 µg/200 µL (Fig. 2B): y=0.003298x
+ 0.03304 (r2=0.754). Subsequent transport studies were conducted using incubation
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times of 60 minutes and 30 minutes for Caco-2 cells and IEC-6 cells, respectively.

Transport kinetics. In both Caco-2 and IEC-6 cells, the uptake of bovine exosomes was
mediated by saturable transport mechanisms. Transport kinetics were modeled using the
Michaelis-Menten equation. In Caco-2 cells, Km and Vmax were 55.5±48.6 µg exosomal
protein/200 µL medium and 0.083±0.057 ng exosomal protein x 81,750 cells−1 x hr−1,
respectively, at 37°C (r2=0.746; Fig. 3A). In IEC-6 cells, Km and Vmax were 152.4 ±39.47
µg/200 µL and 0.140±0.0133 ng exosomal protein x 36,375 cells−1 x 30 min−1,
respectively, at 37°C (r2=0.559; Fig. 3B). When the incubation temperature was
decreased from 37°C to 4°C, the transport rate decreased from 100±56% to 54±13%
using a substrate concentration of 55.5 µg exosomal protein/200 µL in Caco-2 cells
(P<0.05; n=3). Likewise, when the incubation temperature was decreased from 37°C to
4°C, the transport rate decreased from 100±11% to 44±25% using a substrate
concentration of 153 µg exosomal protein/200 µL in IEC-6 cells (P<0.05; n=3).
Subsequent transport studies were conducted using substrate concentrations of 55 µg/200
µL and 153 µg/200 µL in Caco-2 cells and IEC-6 cells, respectively, except for transwell
studies.

Roles of surface glycoproteins and endocytosis. The uptake of bovine milk exosomes
into human and rat intestinal cells depended on surface proteins on both exosomes and
cells. When surface proteins were removed from exosomes or Caco-2 cells were
treatment with proteinase K, exosome uptake decreased to 32±25% and 18±16% of
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controls (P<0.05, n=3) (Fig. 4A). These observations are consistent with previous reports
that the cellular uptake of exosomes is initiated by protein/protein interactions, leading to
vesicle uptake by endocytosis (23-25). When IEC-6 cells were treated with trypsin,
exosome uptake decreased to 82±8% of controls (P<0.05, n=3) (Fig. 4C), indicating that
proteins containing amino lysine and arginine on the cell surface may be involved in
bovine milk exosome uptake. When Caco-2 cells were treated with inhibitors of
endocytosis (cytochalasin D), intracellular vesicle trafficking (brefeldin A), or
carbohydrate competitors the uptake of exosomes decreased to less than 50% of controls
(Fig. 4B). Carbohydrate competitors were equally effective in decreasing exosome
uptake into Caco-2 cells. The effects of these inhibitors and competitors were similar in
IEC-6 cells, although treatments were not statistically significant (P=0.11, n=6) (Fig.
4D).

MiRNA sorting in the intestinal mucosa and reverse transport. When Caco-2 cells were
provided with exosome-supplemented media (275 µg/100 μL) in the apical chamber and
incubated for two hours, the concentrations of miR-29b in the basolateral chamber
increased from 0.018±0.03 fmol/L to 0.094±0.16 fmol/L (P<0.05). When exosomes were
provided with exosome-supplemented media (275 µg/100 μL) in the basolateral chamber
and incubated for two hours, no concentration gradient was detected in the two chambers,
suggesting minimal reverse transport under the experimental conditions: 0.067±0.068
miR-29b fmol/L in the basolateral chamber compared to 0.066±0.11 fmol/L miR-29b in
the apical chamber. Caco-2 cells formed a tight monolayer, judged by a Lucifer yellow
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rejection percentage of 99.7±0.19%.

DISCUSSION
Exosomes are found in many biologial fluids. In the past decade, research has been
focused on but not limited to those found in urine (26, 27), salvia (28), blood (29, 30 ),
and breast milk (13, 31). While much has been discovered regarding exosomes, studies
on mechanisms of intestinal transport of dietary exosomes are lacking. By understanding
the uptake kinetics of bovine milk exosomes, this study provides the foundation to further
explore the mechanism of bovine exosomes in regards to human health. Here we provide
evidence that bovine milk exosomes are absorbed into human colon carcinoma Caco-2
cells and IEC-6 RAT small intestinal cells.
Evidence continues to emerge surrounding miRNA’s and their role in human
health (8, 32, 33). The theory of deitary miRNA absorbance into the human intestinal
muscosa and inducing biological activity in humans continues to gain evidence (3, 3436). In contrast to plant microRNAs, many mammalian microRNAs are protected against
degradation (12) by encapsulation in microvesicles such as exosomes (13, 14, 37). It has
become a controversial topic in the science community if plant miRNAs can in fact effect
human gene expression (3, 38-41). In contrary, a recent report suggests that another
animal product, eggs in nutritionally relevant amounts, can cause a 100% increase in
plasma miRNAs (36).
By using inhibitors of vesicle trafficking and a broad-spectrum proteinase, and by
measuring uptake at 4°C and 37°C, we provide evidence that uptake of bovine milk
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exosomes is a carrier-mediated process in human intestinal cells and that glycoproteins
on the milk exosomes and intestinal cells are involved. High sucrose concentrations have
been associated with decreased levels of receptor-mediate endocytosis (42). By
increasing the levels of glucose and galactose, it’s possible that the hyperosmolar state
decreased the uptake of milk exosomes into Caco-2 cells, indicating bovine milk
exosomes depend on endocytosis to be taken into the cell. We also think it’s possible that
glucose and galactose may be acting as carbohydrate competitors with milk exosomes.
There are some uncertainties associated with our studies of bovine milk exosomes
and will need to be revisited in future studies. First, FM4-64 might alter the structure of
bovine EVs. We are not able to overcome this obstacle at this time. Second, FM4-64 is
believed to fluoresce intensely when inserted into the outer leaflet of the surface
membrane (43), so it’s possible that the bovine exosomes are not fully internalized in the
cell. We find this to be an unlikely possibility due to a study from an independent
laboratory suggesting that milk exosomes enter the mouse circulation intact by crossing
the intestinal mucosa without re-packaging (35). We will carry out future studies to
determine if we also can come to this conclusion. Lastly, it is not yet established if
surface proteins in human and rat cells can recognize exosomes from other species.
Because low Km is associated with a higher affinity, we can conclude bovine
exosomes is higher in human Caco-2 cells than rat IEC-6 cells. One could speculate that
the bovine surface glycoproteome is more compatible with human cells than it is with
rats. Current studies in our laboratory include characterization of the glycoproteins
involved in bovine milk exosome transportation. In contrast, the capacity for transport is
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higher in rat IEC-6 cells compared with human Caco-2 cells. One would expect that with
more cells, the transport rates would be higher. When using half as many IEC-6 cells, the
differences become more dramatic between transport rates. This makes logical sense
based on the absorption kinetics of humans absorbing milk microRNA (3). This study out
of our laboratory provided the evidence to propose that the upper intestine is the primary
site of milk exosome absorption (3), and we validated it with the IEC-6 cell line in this
study.
Looking forward, the use of milk exosomes may be a promising vehicle for the
oral delivery of drugs. Exosomes can be harvested from cells, but milk proves
advantageous due to the large quantities that can be obtained and the practicality when it
comes to the cost and availability. Cell cultures are often from cancer or mutant cells
which might run the risk of promoting malignant transformation of cells in subjects
treated with such vesicles (44).
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Figure 1
Electron microscopy and western blot.
(A) Electron microscopy images: large field image (15,000 x magnification) and single
exosomes (60,000X magnification).
(B) Western Blot A: anti-C63 (exosome positive control), B: anti-casein (bovine positive
control), C: anti-histone H3 (negative control). All samples were run on the same gel but
the membrane had to be cut to allow for probing with distinct antibodies.
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Figure 2
(A) Exosome uptake into human colon carcinoma Caco-2 cells as a function of time at a
concentration of 110 µg exosome protein/200 µL medium and temperature of 37°C
(n=6.)
(B) Exosome uptake into rat primary intestinal IEC-6 cells as a function of time at a
concentration of 55 µg exosome protein/200 µL medium and temperature of 37°C (n=3).
All panels: Means±SD are reported.
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Figure 3
Saturation kinetics of bovine exosome transport in Caco-2 cells.
(A) Exosome uptake into human colon carcinoma Caco-2 cells as a function of exosome
protein dose in one hour at 37°C (n=6).
(B) Exosome uptake into rat primary intestinal IEC-6 cells as a function of exosome
protein dose in 30 hour at 37°C (n=3). All panels: Means±SD are reported.
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Figure 4
Effects of inhibitors of endocytosis and vesicle trafficking, and carbohydrate competitors
on the uptake of bovine exosomes in human and rat intestinal cells.
(A) Treatment of bovine exosomes or Caco-2 cells with proteinase K prior to analysis of
transport rates. (n=3).
(B) Exosome transport in Caco-2 cells treated with cytochalasin D (Cyt D), brefeldin A
(BFA), or in the presence of carbohydrate competitors (n=5).
(C) Treatment of bovine exosomes or IEC-6 cells with trypsin prior to analysis of
transport rates (n=3).
(D) Exosome transport in IEC-6 cells treated with Cyt D, BFA, or in the presence of
carbohydrate competitors (n=6).
All panels: Means±SD are reported; *p<0.05 vs control.
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Table 1
Quantitative PCR Primers Used to Quantify Gene Expression
microRNA

Forward Primer Sequence 5 – 3’

miSpike

CTC AGG ATG GCG GAG CGG TCT

miR-29b

GTA GCA CCA TTT GAA TCA GTG TT
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CHAPTER 3
CONCLUSIONS
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FUTURE STUDIES & CONCLUSION
Moving forward our lab is currently conducting a study analyzing phenotypic
effects potentially due to microRNA provided by the diet. Mice are being fed an exosome
plus diet, where microRNAs are present, or an exosome minus diet, in which microRNAs
are depleted through sonication. Plasma and a number of different tissues will be
analyzed at different stages in life. The success of breeding and offspring survival will be
analyzed as well. Our lab will also test feeding human adults soy infant formula and the
same soy infant formula but supplemented with bovine milk exosomes. We predict the
miRNA plasma levels will not change following consumption of soy formula alone, but
when supplemented with bovine exosomes, may result in plasma miRNA increases
similar to our prior study (1).
Many questions remain unanswered about extracellular vesicles, and much
research is still needed, but so far, the future of extracellular vesicles in drug delivery is
looking promising (2, 3). A remarkable study recently published created a treatment by
loading exosomes with a catalase, a potent antioxidant, for the treatment of Parkinson’s
Disease in mice (2). A clinical trial currently recruiting participants will access if plant
exosomes loaded with curcumin can effectively deliver curcumin to colon cancer and
normal colon mucosa tissues as a dietary supplement (4).
Technical aspects of EV research, such as storage, isolation, and other factors are
being explored to determine the best technique for harvesting and preserving EVs (5-7).
Mammal and food derived EVs currently have no established nomenclature for
classification and isolation procedures (8). This study, and many others, is just the
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beginning of a path that will perhaps lead to improved insight on drug and nutrient
delivery systems.
MicroRNAs have been implicated in many aspects of human health and disease
including bone health, inflammatory bowel disease, metabolic syndrome (9-12) cancer
(13), and cystic fibrosis (14-16). Though it is important to note that some miRNAs may
have adverse effects (17-19). More in-depth studies to determine if dietary microRNAs
can survive and pass the human gastrointestinal tract are needed. As the great Frenchmen
Brillat-Savarin once said, “Tell me what you eat, and I will tell you what you are.” This
may continue to ring true with even deeper meaning than initially thought if dietary
microRNAs from other species can indeed impact gene expression in humans.

50
References
1.
Baier SR, Nguyen C, Xie F, Wood JR, Zempleni J. MicroRNAs are absorbed in
biologically meaningful amounts from nutritionally relevant doses of cow’s milk and
affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell
cultures, and mouse livers. J Nutr. 2014;144:1495-500.
2.
Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al.
Exosomes as drug delivery vehicles for Parkinson's disease therapy. Journal of controlled
release : official journal of the Controlled Release Society. 2015;207:18-30. Epub
2015/04/04.
3.
Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, et al. A novel nanoparticle
drug delivery system: the anti-inflammatory activity of curcumin is enhanced when
encapsulated in exosomes. Mol Ther. 2010;18(9):1606-14. Epub 2010/06/24.
4.
Miller DM. Phase I Clinical Trial Investigating the Ability of Plant Exosomes to
Deliver Curcumin to Normal and Malignant Colon Tissue. 2015.
5.
Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, et al.
Collection, storage, preservation, and normalization of human urinary exosomes for
biomarker discovery. Kidney Int. 2006;69(8):1471-6. Epub 2006/02/28.
6.
Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, et al.
Comparison of ultracentrifugation, density gradient separation, and immunoaffinity
capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012;56(2):293-304.
7.
Szatanek R, Baran J, Siedlar M, Baj-Krzyworzeka M. Isolation of extracellular
vesicles: Determining the correct approach (Review). Int J Mol Med. 2015. Epub
2015/04/23.
8.
Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal
experimental requirements for definition of extracellular vesicles and their functions: a
position statement from the International Society for Extracellular Vesicles. Journal of
extracellular vesicles. 2014;3:26913. Epub 2014/12/30.
9.
Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, et al. Signature
microRNA expression profile of essential hypertension and its novel link to human
cytomegalovirus infection. Circulation. 2011;124(2):175-84.
10.
Fernandez-Valverde SL, Taft RJ, Mattick JS. MicroRNAs in beta-cell biology,
insulin resistance, diabetes and its complications. Diabetes. 2011;60(7):1825-31.

51
11.
Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM. MicroRNA-30c
reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and
lipoprotein secretion. Nat Med. 2013;19(7):892-900.
12.
Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma
microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2
diabetes. Circ Res. 2010;107(6):810-7.
13.
Amodio N, Di Martino MT, Foresta U, Leone E, Lionetti M, Leotta M, et al. miR29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the
activation of a feedback loop with the transcription factor Sp1. Cell Death Dis.
2012;3:e436.
14.
Gillen AE, Gosalia N, Leir SH, Harris A. MicroRNA regulation of expression of
the cystic fibrosis transmembrane conductance regulator gene. Biochem J.
2011;438(1):25-32. Epub 2011/06/22.
15.
Nothnick WB. The role of micro-RNAs in the female reproductive tract.
Reproduction. 2012;143(5):559-76.
16.
Abu-Halima M, Hammadeh M, Schmitt J, Leidinger P, Keller A, Meese E, et al.
Altered microRNA expression profiles of human spermatozoa in patients with different
spermatogenic impairments. Fertil Steril. 2013;99(5):1249-55 e16.
17.
Komatsu S, Ichikawa D, Hirajima S, Kawaguchi T, Miyamae M, Okajima W, et
al. Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and
monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer.
2014;111(8):1614-24.
18.
Wu K, Li L, Li S. Circulating microRNA-21 as a biomarker for the detection of
various carcinomas: an updated meta-analysis based on 36 studies. Tumour Biol: J
Internat Soc Oncodevelop Biol Med. 2014.
19.
Bhattacharyya S, Balakathiresan NS, Dalgard C, Gutti U, Armistead D, Jozwik C,
et al. Elevated miR-155 promotes inflammation in cystic fibrosis by driving
hyperexpression of interleukin-8. J Biol Chem. 2011;286(13):11604-15. Epub
2011/02/02.

